References
Ya. Buresh, O. Bureshova, and J. P. Houston, Methods and Basic Experiments for the Study of the Brain and Behavior [in Russian], Vysshaya Shkola, Moscow (1991).
N. V. Gulyaeva, N. A. Lazareva, M. L. Libe et al., “Oxidative stress in the brain following intraventricular administration of ethylcholine aziridinium (AF64A),” Brain Res.,726, 174 (1996).
T. Maurice, B. P. Lockhart, and A. Privat, “Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction,” Brain Res.,706, 181 (1996).
T. A. Perry, E. Torres, C. Czech, et al., “Cognitive and motor function in transgenic mice carrying excess copies of the 695 and 751 amino acid isoforms of the amyloid protein precursor gene,” Alzheimer’s Research,1, No. 1, 5 (1995).
M. Sarter, G. Bodewitz, and D. N. Stephens, “Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist of β-carbolines,” Psychopharmacology,94, 491 (1988).
D. J. Selkoe, “The molecular pathology of Alzheimer’s disease,” Neuron6, 487 (1991).
Additional information
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow. Translated from Zhurnal Vysshei Nervnoi Deyatel’nosti imeni I. P. Pavlova, Vol. 47, No. 3, pp. 597–600, May–June, 1997.
Rights and permissions
About this article
Cite this article
Stepanichev, M.Y., Lazareva, N.A., Onufriev, M.V. et al. Effects of doses of fragment (25–35) of β-amyloid peptide on behavior in rats. Neurosci Behav Physiol 28, 564–566 (1998). https://doi.org/10.1007/BF02463018
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02463018